Netarsudil

RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Who should not take it

None.

2 dosage and administration

The recommended dosage is one drop in the affected eye(s) once daily in the evening.

If one dose is missed, treatment should continue with the next dose in the evening. Twice a day dosing is not well tolerated and is not recommended. If RHOPRESSA is to be used concomitantly with other topical ophthalmic drug products to lower IOP, administer each drug product at least 5 minutes apart.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Netarsudil; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/netarsudil
APA 7th: sofidex. (2026, August 3). Netarsudil. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/netarsudil
AMA 11th: Netarsudil. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/netarsudil

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.